Literature DB >> 17338838

Aortic morphometry and microcephaly in hypoplastic left heart syndrome.

Amanda J Shillingford1, Richard F Ittenbach, Bradley S Marino, Jack Rychik, Robert R Clancy, Thomas L Spray, J William Gaynor, Gil Wernovsky.   

Abstract

Microcephaly is a marker of abnormal fetal cerebral development, and a known risk factor for cognitive dysfunction. Patients with hypoplastic left heart syndrome have been found to have an increased incidence of abnormal neurodevelopmental outcomes. We hypothesized that reduced cerebral blood flow from the diminutive ascending aorta and transverse aortic arch in the setting of hypoplastic left heart syndrome may influence fetal growth of the brain. The purpose of our study, therefore, was to define the prevalence of microcephaly in full-term infants with hypoplastic left heart syndrome, and to investigate potential cardiac risk factors for microcephaly. We carried out a retrospective review of full-term neonates with hypoplastic left heart syndrome. Eligible patients had documented indexes of birth weight, and measurements of length, and head circumference, as well as adequate echocardiographic images for measurement of the diameters of the ascending aorta and transverse aortic arch. We used logistic regression for analysis of the data. A total of 129 neonates met the criteria for inclusion, with 15 (12%) proving to have microcephaly. The sizes of their heads were disproportionately smaller than their weights (p less than 0.001) and lengths (p less than 0.001) at birth. Microcephaly was associated with lower birth weight (p less than 0.001), lower birth length (p equal to 0.007), and a smaller diameter of the ascending aorta (p equal to 0.034), but not a smaller transverse aortic arch (p equal to 0.619), or aortic atresia (p equal to 0.969). We conclude that microcephaly was common in this cohort of neonates with hypoplastic left heart syndrome, with the size of the head being disproportionately smaller than weight and length at birth. Microcephaly was associated with a small ascending aorta, but not a small transverse aortic arch. Impairment of somatic growth may be an additional factor in the development of microcephaly in these neonates.

Entities:  

Mesh:

Year:  2007        PMID: 17338838     DOI: 10.1017/S1047951107000248

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  33 in total

1.  Oxygen supply to the fetal cerebral circulation in hypoplastic left heart syndrome: a simulation study based on the theoretical models of fetal circulation.

Authors:  Sayaka Sakazaki; Satoshi Masutani; Masaya Sugimoto; Masanori Tamura; Seiko Kuwata; Clara Kurishima; Hirofumi Saiki; Yoichi Iwamoto; Hirotaka Ishido; Hideaki Senzaki
Journal:  Pediatr Cardiol       Date:  2014-11-15       Impact factor: 1.655

2.  Diffusion-weighted imaging in fetuses with severe congenital heart defects.

Authors:  J I Berman; S E G Hamrick; P S McQuillen; C Studholme; D Xu; R G Henry; L K Hornberger; O A Glenn
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

Review 3.  Neurodevelopmental Outcomes in Children With Congenital Heart Disease-What Can We Impact?

Authors:  Gil Wernovsky; Daniel J Licht
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

4.  Hypoplastic Left Heart Syndrome is not Associated with Worse Clinical or Neurodevelopmental Outcomes Than Other Cardiac Pathologies After the Norwood-Sano Operation.

Authors:  Billie-Jean Martin; I De Villiers Jonker; Ari R Joffe; Gwen Y Bond; Bryan V Acton; David B Ross; Charlene M T Robertson; Ivan M Rebeyka; Joseph Atallah
Journal:  Pediatr Cardiol       Date:  2017-03-24       Impact factor: 1.655

5.  Gestational Age, Birth Weight, and Outcomes Six Years After the Norwood Procedure.

Authors:  Thomas A Miller; Nancy S Ghanayem; Jane W Newburger; Brian W McCrindle; Chenwei Hu; Aaron G DeWitt; James F Cnota; Felicia L Tractenberg; Victoria L Pemberton; Michael J Wolf; Jodie K Votava-Smith; Carlen G Fifer; Linda M Lambert; Amee Shah; Eric M Graham; Christian Pizarro; Jeffrey P Jacobs; Stephen G Miller; L LuAnn Minich
Journal:  Pediatrics       Date:  2019-04-12       Impact factor: 7.124

6.  Glial fibrillary acidic protein as a biomarker for brain injury in neonatal CHD.

Authors:  Stephanie L McKenney; Fahad F Mansouri; Allen D Everett; Ernest M Graham; Irina Burd; Priya Sekar
Journal:  Cardiol Young       Date:  2016-01-20       Impact factor: 1.093

7.  Cerebral blood flow characteristics and biometry in fetuses undergoing prenatal intervention for aortic stenosis with evolving hypoplastic left heart syndrome.

Authors:  Doff B McElhinney; Carol B Benson; David W Brown; Louise E Wilkins-Haug; Audrey C Marshall; Linda Zaccagnini; Wayne Tworetzky
Journal:  Ultrasound Med Biol       Date:  2010-01       Impact factor: 2.998

8.  Hyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology.

Authors:  Jean A Ballweg; Richard F Ittenbach; Judy Bernbaum; Marsha Gerdes; Troy E Dominguez; Elaine H Zackai; Robert R Clancy; James William Gaynor
Journal:  Eur J Cardiothorac Surg       Date:  2009-08-20       Impact factor: 4.191

9.  Umbilical artery systolic to diastolic ratio is associated with growth and myocardial performance in infants with hypoplastic left heart syndrome.

Authors:  Thomas A Miller; Lisa Joss-Moore; Shaji C Menon; Cindy Weng; Michael D Puchalski
Journal:  Prenat Diagn       Date:  2013-11-28       Impact factor: 3.050

10.  Ethics of cardiac transplantation in hypoplastic left heart syndrome.

Authors:  Alexander A Kon
Journal:  Pediatr Cardiol       Date:  2009-04-25       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.